August, 2024
August 2024
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Gevorg Tamamyan: It was a great pleasure interviewing Pasi Jänne
Apr 4, 2024, 13:16

Gevorg Tamamyan: It was a great pleasure interviewing Pasi Jänne

Gevorg Tamamyan shared on LinkedIn:

“It was a great pleasure interviewing Pasi Jänne, a world-known translational medical oncologist focused on improving the lives and outcomes of patients with lung cancer, Senior Vice President for Translational Medicine at Dana-Farber Cancer Institute, and the Recipient of the 2024 Medal of Honor from the American Cancer Society. The video of the interview will be available soon on OncoDaily.
Lillian Siu, thank you very much for the great recommendation.”

Source: Gevorg Tamamyan/LinkedIn

Gevorg Tamamyan is the Editor-in-chief of OncoDaily, Head of the Pediatric Cancer and Blood Disorders Center of Armenia, Chairman and Professor of the Department of Hematology and Pediatric Oncology at Yerevan State Medical University, CEO of the Immune Oncology Research Institute, President-Elect of the Pediatric Oncology East and Mediterranean (POEM) Group. He is also the Adviser to the Rector of YSMU and to the Director of the Yeolyan Hematology and Oncology Center. He is a Co-Founder and Board Member of the Armenian Association of Hematology and Oncology, City of Smile Charitable Foundation, Co-Founder and Chairman of the Board of the Institute of Cancer and Crisis, the Former President of the Harvard Club of Armenia.
Dr. Tamamyan is the Past-Chair of the American Society of Clinical Oncology (ASCO) IDEA Steering Group and International Society of Pediatric Oncology (SIOP) PODC Supportive care WG, Ambassador of the Society of Hematologic Oncology. He was selected for the ASCO Leadership Development Program and currently is a member of the ASCO International Committee. He is a recipient of numerous awards and distinctions, among them the ASCO IDEA and LIFe Awards, 40 under 40 in Cancer Award, he was recognized as a Young Leader of the International Agency for Cancer Research (IARC) and Union for International Cancer Control (UICC).
For more detailed information about Dr. Tamamyan, you can visit the Immune Oncology Research Institute’s website.